Insys founder John Kapoor, 4 others, convicted in opioid racketeering and bribery scheme


A federal jury in Boston convicted John Kapoor, the founder and former chairman of Insys Therapeutics, and four former colleagues on Thursday in connection with a scheme to bribe doctors to prescribe the highly addictive and potent opioid fentanyl, sold by Insys in spray form. Kapoor, 76, is now the highest-ranking pharmaceutical executive convicted in a case related to America's opioid crises. He and his four co-defendants — Michael Gurry, Richard Simon, Sunrise Lee, and Joseph Rowan, all former Insys managers and executives — each face up to 20 years in prison.
The five pharmaceutical executives were convicted of racketeering conspiracy; prosecutors said the scheme included not only bribing doctors also defrauding insurance companies, misleading them into paying for the expensive fentanyl spray, Subsys, approved only for terminal cancer patients. The co-defendants denied wrongdoing and will appeal, their lawyers said. Insys, which agreed to pay $150 million or more in a settlement with the Justice Department last summer, said Thursday that the scheme was limited to "the actions of a select few former employees."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
What to know before lending money to family or friends
the explainer Ensure both your relationship and your finances remain intact
By Becca Stanek, The Week US
-
A running list of Trump's second-term national security controversies
In Depth Several scandals surrounding national security have rocked the Trump administration
By Justin Klawans, The Week US
-
The tobacco industry could be the beneficiary of health agency cuts
The explainer Anti-tobacco initiatives could be up in smoke
By Devika Rao, The Week US
-
Markets notch worst quarter in years as new tariffs loom
Speed Read The S&P 500 is on track for its worst month since 2022 as investors brace for Trump's tariffs
By Peter Weber, The Week US
-
Tesla Cybertrucks recalled over dislodging panels
Speed Read Almost every Cybertruck in the US has been recalled over a stainless steel panel that could fall off
By Justin Klawans, The Week US
-
Crafting emporium Joann is going out of business
Speed Read The 82-year-old fabric and crafts store will be closing all 800 of its stores
By Peter Weber, The Week US
-
Trump's China tariffs start after Canada, Mexico pauses
Speed Read The president paused his tariffs on America's closest neighbors after speaking to their leaders, but his import tax on Chinese goods has taken effect
By Peter Weber, The Week US
-
Chinese AI chatbot's rise slams US tech stocks
Speed Read The sudden popularity of a new AI chatbot from Chinese startup DeepSeek has sent U.S. tech stocks tumbling
By Peter Weber, The Week US
-
US port strike averted with tentative labor deal
Speed Read The strike could have shut down major ports from Texas to Maine
By Peter Weber, The Week US
-
Biden expected to block Japanese bid for US Steel
Speed Read The president is blocking the $14 billion acquisition of U.S. Steel by Japan's Nippon Steel, citing national security concerns
By Peter Weber, The Week US
-
Judges block $25B Kroger-Albertsons merger
Speed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal
By Peter Weber, The Week US